Forbes selected biotechnological companies in China & Hong Kong 2018, based on sales
This statistic shows the leading companies in biotechnology and drugs in mainland China and Hong Kong according to Forbes in 2019, based on sales value. According to Forbes Asia's 200 Best Under a Billion 2018 list, the sales value of Chinese company Pharmablock Sciences., engaged in the drug molecular block designing and process development business, reached approximately 71 million U.S. dollars in 2018.